| Literature DB >> 33213251 |
Linhai He1, Zhiyong Zhang1, E Xiao2, Yang He3, Yi Zhang3,4.
Abstract
OBJECTIVE: To comprehensively review the literature and summarize the results from human and animal studies related to the possible causes and pathogenesis of traumatic temporomandibular joint ankylosis (TMJA).Entities:
Keywords: Traumatic temporomandibular joint ankylosis; bone mass; bone remodeling; fracture healing; pathogenesis; review
Mesh:
Year: 2020 PMID: 33213251 PMCID: PMC7686630 DOI: 10.1177/0300060520972073
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Articles reviewed in the present study.
| First author, year | Research object | Results and conclusion | Reference No. |
|---|---|---|---|
| Yan et al., 2013 | Animal model | Mild injury of glenoid fossa leads to fibrotic ankylosis whereas severe injury of glenoid fossa leads to bony TMJA | 4 |
| Deng et al., 2016 | Animal model | The lateral pterygoid simulates the effects of distraction osteogenesis and contributes to TMJA | 21 |
| Meng et al., 2009 | Hypothesis | Distraction osteogenesis of the lateral pterygoid muscle plays an important role in TMJA formation | 20 |
| Liu et al., 2012 | Animal model | Lateral pterygoid muscle reconstructs the condyle fracture healing shape, which causes TMJA | 22 |
| Yang et al., 2020 | Animal model | Condylar fibrous layer removal (instead of glenoid fibrous layer removal) combined with discectomy leads to traumatic TMJA | 15 |
| Wang et al., 2019 | Animal model | Articular fibrous layer removal combined with discectomy leads to traumatic TMJA | 14 |
| Zhao et al., 2020 | Animal modelHuman samples | Macrophage depletion reduces chondrogenesis and prevents TMJA bone formation | 13 |
| Liang et al., 2019 | Animal model | Higher expression of angiogenic factors (Hif-1α, VEGF, Ang1, vWF) in bony TMJA than fibrotic TMJA and increased angiogenesis might contribute to TMJA | 17 |
| Bhatt et al., 2013 | Hypothesis | Hypercoagulability/reduced fibrinolytic activity secondary to protein C deficiency might play a role in TMJA | 18 |
| Yan et al., 2012 | Hypothesis | The development of TMJA is similar to the course of hypertrophic nonunion from medical history, etiology, imaging features, histology, and disease turnover | 5 |
| Li et al., 2014 | Human radiologic and histology samples | Bony traumatic TMJA forms by osteophyte proliferation and endochondral ossification | 12 |
| Porto et al., 2011 | Animal model | MSC application induces more bone formation in the TMJ damage area and more severe ankylosis symptoms than bone graft application | 8 |
| Xiao et al., 2013 | Human samples | BMSCs derived from radiolucent zone of TMJA exhibit lower osteogenic potential, and radiolucent zone might be an important pool of BMSCs for bone formation | 7 |
| He et al., 2015 | Human samples | Bone remodeling suppression caused by osteoclast deficiency contributes to bone mass formation of TMJA | 6 |
| Yan et al., 2014a | Animal model | Wnt signaling is involved in bone formation of TMJA | 10 |
| Yan et al., 2014b | Animal model | Osteogenic mRNA expression of bony TMJA was higher than that of fibrotic TMJA but lower than that of condyle fracture healing, suggesting that the course of TMJA is similar to that of hypertrophic nonunion | 9 |
| Pilmane and Skagers, 2011 | Human samples | High TGF-β1 expression and persistent Msx2 expression lead to persistent bone formation and limited programmed cell death in TMJA | 11 |
| Duan et al., 2015 | Human samples | Fibrocartilage and chondro-osseous structures exist in the TMJA joint space, suggesting the main pattern of TMJA bone formation | 16 |
| Corso et al., 2019 | Human samples | CC genotype in additive model and C allele in dominant model have higher possibility of association with TMJA, suggesting that OPG polymorphism is a potential predictive marker of TMJA | 19 |
TMJA, temporomandibular joint ankylosis; Hif-1α, hypoxia-inducible factor 1-alpha; VEGF, vascular endothelial growth factor; Ang1, angiopoietin 1; vWF, von Willebrand factor; MSCs, mesenchymal stem cells; BMSCs, bone marrow-derived mesenchymal stem cells; TGF-β1, transforming growth factor-beta 1; Msx2, msh homeobox 2; OPG, osteoprotegerin.